retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity Retatrutide: The "Triple G" Peptide That Could Rival Bariatric Surgery (And Why You Shouldn't Wait) Retatrutide for weight loss: Study

Retatrutide Phase 3 Clinical Trials Retatrutide is still in phase 3 clinical trials and has not yet been approved by the FDA

Med-Spa Appointment Request "*" indicates required fields

Many compounding pharmacies create versions of these drugs that may not meet the same safety and quality standards as FDA-approved products

Ivm Health offers a flexible process for adjusting medication dosages

Advanced Digestive Enzyme Complex with 14 Enzymes: GLP1 supplement with a comprehensive blend of digestive enzymes such as amylase, protease, and lactase to support protein, carbohydrate, and fat digestion and help maintain digestive comfort

This section will briefly review what we know about the current safety data of GLP-1 and GLP-1/GIP agonists, and factors that may promote long term clinical use of these agents in obesity